56
Views
10
CrossRef citations to date
0
Altmetric
Original Research

Overexpression of RALY promotes migration and predicts poor prognosis in hepatocellular carcinoma

, , , , , & show all
Pages 5559-5572 | Published online: 09 Nov 2018

References

  • de SouzaJAHuntBAsirwaFCAdebamowoCLopesGGlobal health equity: Cancer care outcome disparities in high-, middle-, and low-income countriesJ Clin Oncol201634161326578608
  • TorreLASauerAMChenMSJrKagawa-SingerMJemalASiegelRLCancer statistics for Asian Americans, Native Hawaiians, and Pacific Islanders, 2016: Converging incidence in males and femalesCA Cancer J Clin201666318220226766789
  • FanSTMau LoCPoonRTContinuous improvement of survival outcomes of resection of hepatocellular carcinoma: a 20-year experienceAnn Surg2011253474575821475015
  • LeiZLiJWuDNomogram for preoperative estimation of microvascular invasion risk in hepatitis B virus-related hepatocellular carcinoma within the Milan criteriaJAMA Surg2016151435636326579636
  • JiangLYanQFangSCalcium-binding protein 39 promotes hepatocellular carcinoma growth and metastasis by activating extracellular signal-regulated kinase signaling pathwayHepatology20176651529154528605041
  • Bondy-ChorneyEBaldwinRMDidillonAChabotBJasminBJCôtéJRNA binding protein RALY promotes Protein Arginine Methyltransferase 1 alternatively spliced isoform v2 relative expression and metastatic potential in breast cancer cellsInt J Biochem Cell Biol201791Pt B12413528733251
  • TsofackSPGarandCSeredukCNONO and RALY proteins are required for YB-1 oxaliplatin induced resistance in colon adenocarcinoma cell linesMol Cancer20111014522118625
  • SamimiGManorekGCastelRcDNA microarray-based identification of genes and pathways associated with oxaliplatin resistanceCancer Chemother Pharmacol200555111115378272
  • MahWCThurnherrTChowPKMethylation profiles reveal distinct subgroup of hepatocellular carcinoma patients with poor prognosisPLoS One201498e10415825093504
  • SungWKZhengHLiSGenome-wide survey of recurrent HBV integration in hepatocellular carcinomaNat Genet201244776576922634754
  • BarrettTWilhiteSELedouxPNCBI GEO: archive for functional genomics data sets--updateNucleic Acids Res201341Database issueD991D99523193258
  • HuangCSZhaiJMZhuXXBTG2 is down-regulated and inhibits cancer stem cell-Like features of side population cells in hepatocellular carcinomaDig Dis Sci201762123501351029098552
  • FornerAReigMBruixJHepatocellular carcinomaLancet2018391101271301131429307467
  • BadvieSHepatocellular carcinomaPostgrad Med J20007689141110622772
  • MinagawaMIkaiIMatsuyamaYYamaokaYMakuuchiMStaging of hepatocellular carcinoma: assessment of the Japanese TNM and AJCC/UICC TNM systems in a cohort of 13,772 patients in JapanAnn Surg2007245690992217522517
  • ChengCHLeeCFWuTHEvaluation of the new AJCC staging system for resectable hepatocellular carcinomaWorld J Surg Oncol2011911421958080
  • LiuPHHsuCYHsiaCYPrognosis of hepatocellular carcinoma: Assessment of eleven staging systemsJ Hepatol201664360160826551516
  • KeeKMWangJHLinCYWangCCChengYFLuSNValidation of the 7th edition TNM staging system for hepatocellular carcinoma: an analysis of 8,828 patients in a single medical centerDig Dis Sci20135892721272823703450
  • CornellaNTebaldiTGasperiniLThe hnRNP RALY regulates transcription and cell proliferation by modulating the expression of specific factors including the proliferation marker E2F1J Biol Chem201729248196741969228972179
  • RossiAMoroATebaldiTIdentification and dynamic changes of RNAs isolated from RALY-containing ribonucleoprotein complexesNucleic Acids Res201745116775679228379492
  • SchittekBPsennerKSauerBMeierFIftnerTGarbeCThe increased expression of Y box-binding protein 1 in melanoma stimulates proliferation and tumor invasion, antagonizes apoptosis and enhances chemoresistanceInt J Cancer2007120102110211817266041
  • ShiotaMYokomizoAItsumiMTwist1 and Y-box-binding protein-1 promote malignant potential in bladder cancer cellsBJU Int20111082 Pt 2E142E14921083641
  • YahataHKobayashiHKamuraTIncreased nuclear localization of transcription factor YB-1 in acquired cisplatin-resistant ovarian cancerJ Cancer Res Clin Oncol20021281162162612458343
  • ThieryJPAcloqueHHuangRYNietoMAEpithelial-mesenchymal transitions in development and diseaseCell2009139587189019945376
  • HanJWangFLanYKIFC1 regulated by miR-532-3p promotes epithelial-to-mesenchymal transition and metastasis of hepatocellular carcinoma via gankyrin/AKT signalingOncogene Epub2018816
  • SteinwaySNZañudoJGDingWNetwork modeling of TGFβ signaling in hepatocellular carcinoma epithelial-to-mesenchymal transition reveals joint sonic hedgehog and Wnt pathway activationCancer Res201474215963597725189528
  • ZhuKDaiZPanQMetadherin promotes hepatocellular carcinoma metastasis through induction of epithelial-mesenchymal transitionClin Cancer Res201117237294730221976539